REKVINA LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.5 INR | -.--% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: March | 2018 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 31.53 | 27.13 | 27.13 |
| Enterprise Value (EV) 1 | 32.12 | 27.12 | 27.84 |
| P/E ratio | -40.2 x | -34.6 x | -3,641 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | -614 x | -237 x | -37.8 x |
| FCF Yield | -0.16% | -0.42% | -2.65% |
| Price to Book | 7.77 x | 196 x | 206 x |
| Nbr of stocks (in thousands) | 6,028 | 6,028 | 6,028 |
| Reference price 2 | 5.230 | 4.500 | 4.500 |
| Announcement Date | 19-01-02 | 23-09-06 | 23-09-06 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2022 | 2023 |
|---|---|---|---|
| Net sales | - | - | - |
| EBITDA | - | - | - |
| EBIT 1 | -0.9912 | -0.755 | -0.0406 |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) 1 | -0.7984 | -0.7888 | -0.007452 |
| Net income 1 | -0.7984 | -0.7888 | -0.007452 |
| Net margin | - | - | - |
| EPS 2 | -0.1300 | -0.1300 | -0.001236 |
| Free Cash Flow 1 | -0.0523 | -0.1143 | -0.7371 |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 19-01-02 | 23-09-06 | 23-09-06 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 0.59 | - | 0.72 |
| Net Cash position 1 | - | 0 | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow 1 | -0.05 | -0.11 | -0.74 |
| ROE (net income / shareholders' equity) | -17.9% | -148% | -5.5% |
| ROA (Net income/ Total Assets) | -7.79% | -21.7% | -1.29% |
| Assets 1 | 10.26 | 3.635 | 0.578 |
| Book Value Per Share 2 | 0.6700 | 0.0200 | 0.0200 |
| Cash Flow per Share 2 | 0.2400 | 0 | 0.0200 |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 19-01-02 | 23-09-06 | 23-09-06 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- VINRKLB Stock
- Financials Rekvina Laboratories Limited
